Intel

Key Takeaways Rapid growth in regenerative and alternative therapies is expanding Healthcare Liability exposures across medspas and healthcare providers. Coverage considerations are multifaceted, with many carriers applying exclusions, limitations, and strict underwriting requirements for non-FDA-approved and off-label treatments. A complex regulatory environment, driven by both federal and state oversight, impacts how Healthcare Liability risks are evaluated and underwritten Many claims stem from insufficient informed consent, patient screening, and marketing practices…

Misleading marketing materials, website content and social media posts can quickly become a significant Healthcare Liability exposure. In this short clip from our recent webinar on regenerative and alternative therapies, Lily Chetosky, Broker, Professional Liability, Burns & Wilcox, Chicago, Illinois, explains how patient expectations shaped by marketing can lead to costly claims. https://vimeo.com/1177367526/0dad2278f1?share=copy&fl=sv&fe=ci  

Inadequate patient screening in Telehealth can create significant Healthcare Liability exposure. In this short clip from our recent webinar on regenerative and alternative therapies, Kelli Bernstein, Inside Broker, Brokerage Division, Burns & Wilcox, Atlanta, Georgia, explains how gaps in screening and evaluation can lead to increased risk and potential claims. https://vimeo.com/1177366805/c08e5cfc77?share=copy&fl=sv&fe=ci  

Understanding the distinction between product and provider exposure is critical in Healthcare Liability. In this short clip from our recent webinar on regenerative and alternative therapies, special guest Carrie Roberts, RPLU, Vice President, Professional Brokerage Division, GenStar Insurance Services, explains how these differences influence risk evaluation and coverage. https://vimeo.com/1177361685/71abe58095?fl=ip&fe=ec  

Regenerative and alternative therapies—such as peptides, NAD+, ketamine, and stem cells—are rapidly expanding across healthcare and medspa settings. While these treatments present new opportunities for providers, they also introduce complex Healthcare Liability exposures. Now available on demand, this webinar features experts from Burns & Wilcox and GenStar Insurance Services as they explore evolving standards of care, regulatory scrutiny, and coverage…

Inside This Article: A recent Stanford and Harvard study found that medical AI systems generated severe clinical errors in a significant percentage of patient cases. Many healthcare professionals are using AI tools on the job, with one recent survey finding that almost half of nurses use generative AI at work. These reports point to an evolving risk landscape for…

Key Takeaways The E&S P&C market is in a strong position, supported by disciplined underwriting and strong carrier appetite. The E&S marketplace has recorded 14 consecutive years of premium growth, with Casualty lines representing the majority of direct premiums written. Social inflation, nuclear verdicts, and litigation funding continue to influence underwriting and pricing decisions, while tort reform in select states is beginning to…

Inside This Article: Alabama’s attorney general filed a lawsuit alleging that a medical spa administered non-FDA-approved versions of GLP-1 weight loss drugs without informing patients that the formulations were not authorized. The situation underscores growing concerns as medspas rapidly expand weight loss offerings amid strong consumer demand and uneven regulatory oversight. Allegations involving drug misrepresentation or lack of informed consent can…

Capacity, coverage innovation, and emerging exposures are reshaping today’s Professional Liability market. Click below to learn how Burns & Wilcox delivers tailored solutions for healthcare, technology, and other hard-to-place risks.

Key Takeaways: A “softening hard market” is shaping the current landscape, with some sectors seeing rate relief. Inflation and underwriting discipline remain central themes. The E&S market continues to demonstrate significant growth. WSIA recently reported total surplus lines premium reached $46.2 billion for the first six months of 2025—a 13.2% increase over the same period in 2024. Property rates…

With shifting carrier appetites, emerging risks, and the expanding role of the Excess & Surplus (E&S) sector, brokers and agents must remain agile and informed. This session will provide timely insights to help you navigate the fourth quarter and prepare for 2026. Topics include: The latest trends and challenges across each line of business How admitted carriers are reentering previously…

Key Takeaways: Property & Casualty (P&C) market conditions are stabilizing, with increased competition and moderating rates—though CAT-prone regions remain volatile. Excess & Surplus (E&S) carriers remain vital for distressed sectors like Habitational, Hospitality, and Liquor Liability, even as admitted carriers return to select segments. Severe weather is reshaping risk, as seen in recent Texas flooding and California wildfires earlier…